APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline von Montagne, Axel, Nation, Daniel A., Sagare, Abhay P., Barisano, Giuseppe, Sweeney, Melanie D., Chakhoyan, Ararat, Pachicano, Maricarmen, Joe, Elizabeth, Nelson, Amy R., D’Orazio, Lina M., Buennagel, David P., Harrington, Michael G., Benzinger, Tammie L. S., Fagan, Anne M., Ringman, John M., Schneider, Lon S., Morris, John C., Reiman, Eric M., Caselli, Richard J., Chui, Helena C., TCW, Julia, Chen, Yining, Pa, Judy, Conti, Peter S., Law, Meng, Toga, Arthur W., Zlokovic, Berislav V.

Volltext

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction von Nation, Daniel A., Sweeney, Melanie D., Montagne, Axel, Sagare, Abhay P., D’Orazio, Lina M., Pachicano, Maricarmen, Sepehrband, Farshid, Nelson, Amy R., Buennagel, David P., Harrington, Michael G., Benzinger, Tammie L. S., Fagan, Anne M., Ringman, John M., Schneider, Lon S., Morris, John C., Chui, Helena C., Law, Meng, Toga, Arthur W., Zlokovic, Berislav V.

Volltext

The need to show minimum clinically important differences in Alzheimer's disease trials von Liu, Kathy Y, Schneider, Lon S, Howard, Robert

Volltext

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials von Kavirajan, Harish, MD, Schneider, Lon S, MD

Volltext

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria von Dubois, Bruno, Hampel, Harald, Feldman, Howard H, Scheltens, Philip, Aisen, Paul, Andrieu, Sandrine, Bakardjian, Hovagim, Benali, Habib, Bertram, Lars, Blennow, Kaj, Broich, Karl, Cavedo, Enrica, Crutch, Sebastian, Dartigues, Jean-François, Duyckaerts, Charles, Epelbaum, Stéphane, Frisoni, Giovanni B, Gauthier, Serge, Genthon, Remy, Gouw, Alida A, Habert, Marie-Odile, Holtzman, David M, Kivipelto, Miia, Lista, Simone, Molinuevo, José-Luis, O'Bryant, Sid E, Rabinovici, Gil D, Rowe, Christopher, Salloway, Stephen, Schneider, Lon S, Sperling, Reisa, Teichmann, Marc, Carrillo, Maria C, Cummings, Jeffrey, Jack, Cliff R

Volltext

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease von Colom-Cadena, Martí, Spires-Jones, Tara, Zetterberg, Henrik, Blennow, Kaj, Caggiano, Anthony, DeKosky, Steven T, Fillit, Howard, Harrison, John E, Schneider, Lon S, Scheltens, Phillip, de Haan, Willem, Grundman, Michael, van Dyck, Christopher H, Izzo, Nicholas J, Catalano, Susan M

Volltext

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial von Gauthier, Serge, Prof, Feldman, Howard H, Prof, Schneider, Lon S, Prof, Wilcock, Gordon K, Prof, Frisoni, Giovanni B, Prof, Hardlund, Jiri H, MD, Moebius, Hans J, MD, Bentham, Peter, MBChB, Kook, Karin A, PhD, Wischik, Damon J, PhD, Schelter, Bjoern O, Prof, Davis, Charles S, PhD, Staff, Roger T, PhD, Bracoud, Luc, MSc, Shamsi, Kohkan, MD, Storey, John M D, Prof, Harrington, Charles R, PhD, Wischik, Claude M, Prof

Volltext

The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model von Bateman, Randall J, Benzinger, Tammie L, Berry, Scott, Clifford, David B, Duggan, Cynthia, Fagan, Anne M, Fanning, Kathleen, Farlow, Martin R, Hassenstab, Jason, McDade, Eric M, Mills, Susan, Paumier, Katrina, Quintana, Melanie, Salloway, Stephen P, Santacruz, Anna, Schneider, Lon S, Wang, Guoqiao, Xiong, Chengjie

Volltext

Composite cognitive and functional measures for early stage Alzheimer's disease trials von Schneider, Lon S., Goldberg, Terry E.

Volltext

Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-analysis of Randomized, Placebo-Controlled Trials von Schneider, Lon S., Dagerman, Karen, Insel, Philip S.

Volltext

Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence von Nelson, J Craig, M.D, Delucchi, Kevin, Ph.D, Schneider, Lon S., M.D

Volltext

Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists von Yassine, Hussein N., Solomon, Victoria, Thakral, Angad, Sheikh‐Bahaei, Nasim, Chui, Helena C., Braskie, Meredith N., Schneider, Lon. S., Talbot, Konrad

Volltext

Current Alzheimer's disease clinical trials: Methods and placebo outcomes von Schneider, Lon S, Sano, Mary

Volltext

Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials von Goldberg, Terry E, Harvey, Philip D, Wesnes, Keith A, Snyder, Peter J, Schneider, Lon S

Volltext

Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time von Wang, Guoqiao, Kennedy, Richard E, Goldberg, Terry E, Fowler, Mackenzie E, Cutter, Gary R, Schneider, Lon S

Volltext

Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis von Nelson, J. Craig, Delucchi, Kevin L., Schneider, Lon S.

Volltext

Accelerating stem cell trials for Alzheimer's disease von Hunsberger, Joshua G, PhD, Rao, Mahendra, Prof, Kurtzberg, Joanne, Prof, Bulte, Jeff W M, Prof, Atala, Anthony, Prof, LaFerla, Frank M, Prof, Greely, Henry T, Prof, Sawa, Akira, Prof, Gandy, Sam, Prof, Schneider, Lon S, Prof, Doraiswamy, P Murali, Prof

Volltext

A new roadmap for drug development for Alzheimer's disease von Becker, Robert E., Greig, Nigel H., Giacobini, Ezio, Schneider, Lon S., Ferrucci, Luigi

Volltext

Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial von Arellanes, Isabella C., Choe, Nicholas, Solomon, Victoria, He, Xulei, Kavin, Brian, Martinez, Ashley E., Kono, Naoko, Buennagel, David P., Hazra, Nalini, Kim, Giselle, D'Orazio, Lina M., McCleary, Carol, Sagare, Abhay, Zlokovic, Berislav V., Hodis, Howard N., Mack, Wendy J., Chui, Helena C., Harrington, Michael G., Braskie, Meredith N., Schneider, Lon S., Yassine, Hussein N.

Volltext

What the Gantenerumab Trials Teach Us about Alzheimer’s Treatment von Schneider, Lon S.

Volltext